OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Medical and surgical management of advanced Parkinson's disease
Angelo Antonini, Elena Moro, Clécio Godeiro‐Júnior, et al.
Movement Disorders (2018) Vol. 33, Iss. 6, pp. 900-908
Closed Access | Times Cited: 160
Angelo Antonini, Elena Moro, Clécio Godeiro‐Júnior, et al.
Movement Disorders (2018) Vol. 33, Iss. 6, pp. 900-908
Closed Access | Times Cited: 160
Showing 1-25 of 160 citing articles:
The future of stem cell therapies for Parkinson disease
Malin Parmar, Shane Grealish, Claire Henchcliffe
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 2, pp. 103-115
Closed Access | Times Cited: 258
Malin Parmar, Shane Grealish, Claire Henchcliffe
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 2, pp. 103-115
Closed Access | Times Cited: 258
Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach
Angelo Antonini, A. Jon Stoessl, Leah Kleinman, et al.
Current Medical Research and Opinion (2018) Vol. 34, Iss. 12, pp. 2063-2073
Open Access | Times Cited: 208
Angelo Antonini, A. Jon Stoessl, Leah Kleinman, et al.
Current Medical Research and Opinion (2018) Vol. 34, Iss. 12, pp. 2063-2073
Open Access | Times Cited: 208
Parkinson’s Disease: A Review from Pathophysiology to Treatment
Bianca L. B. Marino, Lucilene Rocha de Souza, Kessia P.A. Sousa, et al.
Mini-Reviews in Medicinal Chemistry (2019) Vol. 20, Iss. 9, pp. 754-767
Closed Access | Times Cited: 169
Bianca L. B. Marino, Lucilene Rocha de Souza, Kessia P.A. Sousa, et al.
Mini-Reviews in Medicinal Chemistry (2019) Vol. 20, Iss. 9, pp. 754-767
Closed Access | Times Cited: 169
Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054
Mirosław Bryś, Laura Fanning, Serena Hung, et al.
Movement Disorders (2019) Vol. 34, Iss. 8, pp. 1154-1163
Open Access | Times Cited: 161
Mirosław Bryś, Laura Fanning, Serena Hung, et al.
Movement Disorders (2019) Vol. 34, Iss. 8, pp. 1154-1163
Open Access | Times Cited: 161
Parkinson's disease in the Western Pacific Region
Shen‐Yang Lim, Ai Huey Tan, Azlina Ahmad‐Annuar, et al.
The Lancet Neurology (2019) Vol. 18, Iss. 9, pp. 865-879
Closed Access | Times Cited: 156
Shen‐Yang Lim, Ai Huey Tan, Azlina Ahmad‐Annuar, et al.
The Lancet Neurology (2019) Vol. 18, Iss. 9, pp. 865-879
Closed Access | Times Cited: 156
Advances in Parkinson’s Disease: 200 Years Later
Natalia López‐González del Rey, Ana Quiroga‐Varela, Elisa Garbayo, et al.
Frontiers in Neuroanatomy (2018) Vol. 12
Open Access | Times Cited: 130
Natalia López‐González del Rey, Ana Quiroga‐Varela, Elisa Garbayo, et al.
Frontiers in Neuroanatomy (2018) Vol. 12
Open Access | Times Cited: 130
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review
Angelo Antonini, Per Odin, Rajesh Pahwa, et al.
Advances in Therapy (2021) Vol. 38, Iss. 6, pp. 2854-2890
Open Access | Times Cited: 63
Angelo Antonini, Per Odin, Rajesh Pahwa, et al.
Advances in Therapy (2021) Vol. 38, Iss. 6, pp. 2854-2890
Open Access | Times Cited: 63
Levodopa–entacapone–carbidopa intestinal gel infusion in advanced Parkinson’s disease: real-world experience and practical guidance
Dag Nyholm, Wolfgang H. Jost
Therapeutic Advances in Neurological Disorders (2022) Vol. 15
Open Access | Times Cited: 52
Dag Nyholm, Wolfgang H. Jost
Therapeutic Advances in Neurological Disorders (2022) Vol. 15
Open Access | Times Cited: 52
Management of psychiatric and cognitive complications in Parkinson’s disease
Daniel Weintraub, Dag Aarsland, Roberta Biundo, et al.
BMJ (2022), pp. e068718-e068718
Open Access | Times Cited: 47
Daniel Weintraub, Dag Aarsland, Roberta Biundo, et al.
BMJ (2022), pp. e068718-e068718
Open Access | Times Cited: 47
Toward objective monitoring of Parkinson's disease motor symptoms using a wearable device: wearability and performance evaluation of PDMonitor®
Angelo Antonini, Heinz Reichmann, Giovanni Gentile, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 30
Angelo Antonini, Heinz Reichmann, Giovanni Gentile, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 30
Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach
Gurkaran Singh Baweja, Shankar Gupta, Bhupinder Kumar, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1823-1845
Open Access | Times Cited: 22
Gurkaran Singh Baweja, Shankar Gupta, Bhupinder Kumar, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1823-1845
Open Access | Times Cited: 22
Levodopa–Carbidopa–Entacapone Intestinal Gel in Advanced Parkinson Disease: A Multicenter Real-Life Experience
József Attila Szász, Adriana Octaviana Dulămea, Viorelia Constantin, et al.
American Journal of Therapeutics (2024)
Closed Access | Times Cited: 13
József Attila Szász, Adriana Octaviana Dulămea, Viorelia Constantin, et al.
American Journal of Therapeutics (2024)
Closed Access | Times Cited: 13
Parkinson disease therapy: current strategies and future research priorities
Fabrizio Stocchi, Daniele Bravi, Aron Emmi, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 12, pp. 695-707
Closed Access | Times Cited: 10
Fabrizio Stocchi, Daniele Bravi, Aron Emmi, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 12, pp. 695-707
Closed Access | Times Cited: 10
Revolutionizing our understanding of Parkinson’s disease: Dr. Heinz Reichmann’s pioneering research and future research direction
Masaru Tanaka, László Vécsei
Journal of Neural Transmission (2024) Vol. 131, Iss. 12, pp. 1367-1387
Open Access | Times Cited: 9
Masaru Tanaka, László Vécsei
Journal of Neural Transmission (2024) Vol. 131, Iss. 12, pp. 1367-1387
Open Access | Times Cited: 9
Predictors of Long‐Term Outcome of Subthalamic Stimulation in Parkinson Disease
Francesco Cavallieri, Valérie Fraix, Francesco Bove, et al.
Annals of Neurology (2020) Vol. 89, Iss. 3, pp. 587-597
Closed Access | Times Cited: 60
Francesco Cavallieri, Valérie Fraix, Francesco Bove, et al.
Annals of Neurology (2020) Vol. 89, Iss. 3, pp. 587-597
Closed Access | Times Cited: 60
Validation of Inertial Sensing-Based Wearable Device for Tremor and Bradykinesia Quantification
Houde Dai, Guoen Cai, Zhirong Lin, et al.
IEEE Journal of Biomedical and Health Informatics (2020) Vol. 25, Iss. 4, pp. 997-1005
Closed Access | Times Cited: 56
Houde Dai, Guoen Cai, Zhirong Lin, et al.
IEEE Journal of Biomedical and Health Informatics (2020) Vol. 25, Iss. 4, pp. 997-1005
Closed Access | Times Cited: 56
Motor and non-motor outcomes in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study
Leonardo Lopiano, Nicola Modugno, Pietro Marano, et al.
Journal of Neurology (2019) Vol. 266, Iss. 9, pp. 2164-2176
Open Access | Times Cited: 55
Leonardo Lopiano, Nicola Modugno, Pietro Marano, et al.
Journal of Neurology (2019) Vol. 266, Iss. 9, pp. 2164-2176
Open Access | Times Cited: 55
GSK-3β Contributes to Parkinsonian Dopaminergic Neuron Death: Evidence From Conditional Knockout Mice and Tideglusib
Junyu Li, Shanshan Ma, Jingnan Chen, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 53
Junyu Li, Shanshan Ma, Jingnan Chen, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 53
Clinical implications of gastric complications on levodopa treatment in Parkinson's disease
Ronald F. Pfeiffer, Stuart Isaacson, Rajesh Pahwa
Parkinsonism & Related Disorders (2020) Vol. 76, pp. 63-71
Open Access | Times Cited: 51
Ronald F. Pfeiffer, Stuart Isaacson, Rajesh Pahwa
Parkinsonism & Related Disorders (2020) Vol. 76, pp. 63-71
Open Access | Times Cited: 51
Transcutaneous auricular vagus nerve stimulation improves anxiety symptoms and cortical activity during verbal fluency task in Parkinson's disease with anxiety
Heng Zhang, Aidi Shan, Chenhui Wan, et al.
Journal of Affective Disorders (2024) Vol. 361, pp. 556-563
Closed Access | Times Cited: 6
Heng Zhang, Aidi Shan, Chenhui Wan, et al.
Journal of Affective Disorders (2024) Vol. 361, pp. 556-563
Closed Access | Times Cited: 6
Should there be less emphasis on levodopa‐induced dyskinesia in Parkinson's disease?
К. Ray Chaudhuri, Peter Jenner, Angelo Antonini
Movement Disorders (2019) Vol. 34, Iss. 6, pp. 816-819
Closed Access | Times Cited: 43
К. Ray Chaudhuri, Peter Jenner, Angelo Antonini
Movement Disorders (2019) Vol. 34, Iss. 6, pp. 816-819
Closed Access | Times Cited: 43
Application of the ‘5-2-1’ Screening Criteria in Advanced Parkinson’s Disease: Interim Analysis of DUOGLOBE
Jason Aldred, Marieta Anca‐Herschkovitsch, Angelo Antonini, et al.
Neurodegenerative Disease Management (2020) Vol. 10, Iss. 5, pp. 309-323
Open Access | Times Cited: 43
Jason Aldred, Marieta Anca‐Herschkovitsch, Angelo Antonini, et al.
Neurodegenerative Disease Management (2020) Vol. 10, Iss. 5, pp. 309-323
Open Access | Times Cited: 43
Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
Angelo Antonini, Per Odin, Péter Schmidt, et al.
Parkinsonism & Related Disorders (2021) Vol. 92, pp. 59-66
Open Access | Times Cited: 39
Angelo Antonini, Per Odin, Péter Schmidt, et al.
Parkinsonism & Related Disorders (2021) Vol. 92, pp. 59-66
Open Access | Times Cited: 39
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis
Angelo Antonini, Rajesh Pahwa, Per Odin, et al.
CNS Drugs (2022) Vol. 36, Iss. 12, pp. 1269-1283
Open Access | Times Cited: 23
Angelo Antonini, Rajesh Pahwa, Per Odin, et al.
CNS Drugs (2022) Vol. 36, Iss. 12, pp. 1269-1283
Open Access | Times Cited: 23
Infusion Therapies in the Treatment of Parkinson’s Disease
Teus van Laar, К. Ray Chaudhuri, Angelo Antonini, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 5, pp. 641-657
Open Access | Times Cited: 14
Teus van Laar, К. Ray Chaudhuri, Angelo Antonini, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 5, pp. 641-657
Open Access | Times Cited: 14
